Applied Biosystems: Feb 15, 2007 Feb 15, 2007 Premium Save for later Applied Biosystems has recently introduced 267 new microRNA assays to its TaqMan microRNA assay product line. According to the company, the new assays were added in order to keep in line with the Wellcome Trust Sanger Institute’s miRBase registry. Filed under Gene Silencing/Gene Editing RNAi Breaking News Native Peruvian Genetic Ancestry Linked to Increased Risk of Tuberculosis Progression BforCure Gets CE Mark for 48-Well Flu/COVID Test Kit Cue Health to Lay Off 170 People Cepheid, BioGX to Jointly Develop Monkeypox PCR Test for GeneXpert System OpGen Enters At-Market Agreement to Sell up to $10.7M in Stock The Scan Boosters Chasing Variants The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19. Not Yet The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports. More Proposed for Federal Research Science reports that US House of Representatives panels are seeking to increase federal research funding. PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.